GB1389505A - 3,4-dihydropyridones their production and their medicinal use - Google Patents

3,4-dihydropyridones their production and their medicinal use

Info

Publication number
GB1389505A
GB1389505A GB4084873A GB4084873A GB1389505A GB 1389505 A GB1389505 A GB 1389505A GB 4084873 A GB4084873 A GB 4084873A GB 4084873 A GB4084873 A GB 4084873A GB 1389505 A GB1389505 A GB 1389505A
Authority
GB
United Kingdom
Prior art keywords
alkyl
radical
straight
chain
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4084873A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of GB1389505A publication Critical patent/GB1389505A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
GB4084873A 1972-08-31 1973-08-30 3,4-dihydropyridones their production and their medicinal use Expired GB1389505A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2242787A DE2242787C2 (de) 1972-08-31 1972-08-31 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
GB1389505A true GB1389505A (en) 1975-04-03

Family

ID=5855065

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4084873A Expired GB1389505A (en) 1972-08-31 1973-08-30 3,4-dihydropyridones their production and their medicinal use

Country Status (21)

Country Link
US (1) US3925395A (US07655688-20100202-C00086.png)
JP (1) JPS5626661B2 (US07655688-20100202-C00086.png)
AT (1) AT327902B (US07655688-20100202-C00086.png)
AU (1) AU476373B2 (US07655688-20100202-C00086.png)
BE (1) BE804161A (US07655688-20100202-C00086.png)
CA (1) CA1016946A (US07655688-20100202-C00086.png)
CH (1) CH592061A5 (US07655688-20100202-C00086.png)
DD (1) DD109628A5 (US07655688-20100202-C00086.png)
DE (1) DE2242787C2 (US07655688-20100202-C00086.png)
DK (1) DK131855C (US07655688-20100202-C00086.png)
ES (1) ES418340A1 (US07655688-20100202-C00086.png)
FR (1) FR2197598B1 (US07655688-20100202-C00086.png)
GB (1) GB1389505A (US07655688-20100202-C00086.png)
HU (1) HU167992B (US07655688-20100202-C00086.png)
IE (1) IE38141B1 (US07655688-20100202-C00086.png)
IL (1) IL43080A (US07655688-20100202-C00086.png)
LU (1) LU68325A1 (US07655688-20100202-C00086.png)
NL (1) NL7311832A (US07655688-20100202-C00086.png)
PL (1) PL89430B1 (US07655688-20100202-C00086.png)
SE (1) SE385882B (US07655688-20100202-C00086.png)
ZA (1) ZA735973B (US07655688-20100202-C00086.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
AU3128693A (en) * 1991-11-18 1993-06-15 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
DE60315862T2 (de) * 2002-08-27 2008-05-15 Bayer Healthcare Ag Dihydropyridinonderivate als hne-inhibitoren
US20050252833A1 (en) * 2004-05-14 2005-11-17 Doyle James A Process and apparatus for converting oil shale or oil sand (tar sand) to oil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines

Also Published As

Publication number Publication date
ES418340A1 (es) 1976-03-16
US3925395A (en) 1975-12-09
IL43080A (en) 1977-01-31
PL89430B1 (US07655688-20100202-C00086.png) 1976-11-30
FR2197598A1 (US07655688-20100202-C00086.png) 1974-03-29
DE2242787C2 (de) 1982-01-21
DK131855B (da) 1975-09-15
AT327902B (de) 1976-02-25
FR2197598B1 (US07655688-20100202-C00086.png) 1977-07-15
CA1016946A (en) 1977-09-06
AU476373B2 (en) 1976-09-16
DE2242787A1 (de) 1974-03-14
DD109628A5 (US07655688-20100202-C00086.png) 1974-11-12
IE38141L (en) 1974-02-28
IE38141B1 (en) 1978-01-04
ATA760073A (de) 1975-05-15
DK131855C (da) 1976-02-16
NL7311832A (US07655688-20100202-C00086.png) 1974-03-04
JPS5626661B2 (US07655688-20100202-C00086.png) 1981-06-19
CH592061A5 (US07655688-20100202-C00086.png) 1977-10-14
AU5983573A (en) 1975-03-06
BE804161A (fr) 1974-02-28
SE385882B (sv) 1976-07-26
LU68325A1 (US07655688-20100202-C00086.png) 1973-10-30
HU167992B (US07655688-20100202-C00086.png) 1976-02-28
IL43080A0 (en) 1973-11-28
ZA735973B (en) 1974-10-30
JPS4962483A (US07655688-20100202-C00086.png) 1974-06-17

Similar Documents

Publication Publication Date Title
GB1389509A (en) Dihydropyridinepolyesters their production and their medicinal use
GB1331405A (en) Esters their production and their medicinal use
IE37538B1 (en) New 1,4-dihydropyridine carboxylic acid compounds their production and their medicinal use
GB1384031A (en) N-substituted dihydropyridine compounds their production and their medicinal use
KR850004463A (ko) 디히드로피리딘 유도체의 제조방법
FR2370731A1 (fr) Nouveaux derives de la piperidine polysubstitues, leurs procedes de preparation et leur application pharmaceutique
GB1384504A (en) Bridgeheadheterocyclic compounds their production and their medicinal use
FR2445319A1 (fr) Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2361899A1 (fr) Nouveaux aminoethers de steroides
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
GB1389504A (en) 2-amino-1,4-dihydropyridines their production and their medicinal use
GB1369401A (en) Process for the manufacture of 2-amino-1,4-dihydropyridines and their use as coronary agents
IE782084L (en) Quinolylguanidine derivatives
GB1389505A (en) 3,4-dihydropyridones their production and their medicinal use
EP0219852A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same
FR2378026A1 (fr) Medicaments contenant des derives de sulfure d'hydroxymethyl-2 amino-2' diphenyle
GB1384219A (en) 2-alkylamino-dihydropyridines their production and their medicinal use
JPS5277073A (en) 1-carbamoyl-5-fluorouracil deruvative and anticancer drug containing s ame as effective component
ES434545A1 (es) Procedimiento para la obtencion de 2-amino-6-dialquil-ami- nodihidropiridinas.
SE7703868L (sv) Pyridinderivat
GB1393198A (en) Chromanol nicotinate derivatives
GB1444879A (en) 3-acylamino-6-amino-3,4-dihydro-2-pyridones and their use as medicaments
GB1379005A (en) 2,6-diaminodihydropyridines their production and their medicinal use
GB1421305A (en) 1,4-dihydroquinoline derivatives their production and their medicinal use
IE38064B1 (en) New 2-amino-4h-pyrane compounds their production and their medicinal use

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee